. "4" . "RIV/00216224:14110/14:00076429" . "Zji\u0161t\u011Bn\u00ED p\u0159\u00EDm\u00FDch n\u00E1klad\u016F na l\u00E9\u010Dbu mCRC u pacient\u016F l\u00E9\u010Den\u00FDch bevacizumabem a chemoterapi\u00ED v prvn\u00ED linii l\u00E9\u010Dby s pou\u017Eit\u00EDm klinick\u00FDch a finan\u010Dn\u00EDch dat z\u00EDskan\u00FDch z komlexn\u00EDho onkologick\u00E9ho centra.N\u00E1klady byly hodnoceny do progrese a /nebo do \u00FAmrt\u00ED pacient\u016F.Nejv\u011Bt\u0161\u00ED pod\u00EDl n\u00E1klad\u016F na l\u00E9\u010Dbu p\u0159edstavovala c\u00EDlen\u00E1 biologick\u00E1 l\u00E9\u010Dba." . "Anal\u00FDza n\u00E1klad\u016F na 1. linii l\u00E9\u010Dby metastatick\u00E9ho kolorekt\u00E1ln\u00EDho karcinomu p\u0159i pod\u00E1n\u00ED re\u017Eim\u016F s bevacizumabem \u2013 data z re\u00E1ln\u00E9 klinick\u00E9 praxe v \u010Cesk\u00E9 republice" . . . "I" . . "14110" . "[9C5AE82F9B50]" . . "Klinick\u00E1 onkologie" . . . . "27" . "Anal\u00FDza n\u00E1klad\u016F na 1. linii l\u00E9\u010Dby metastatick\u00E9ho kolorekt\u00E1ln\u00EDho karcinomu p\u0159i pod\u00E1n\u00ED re\u017Eim\u016F s bevacizumabem \u2013 data z re\u00E1ln\u00E9 klinick\u00E9 praxe v \u010Cesk\u00E9 republice"@cs . "Demlov\u00E1, Regina" . . "3039" . . "The assessment of direct cost of bevacizumab in the treatment of mCRC in the first line therapy in Czech Republic. Cost were obtained from a comprehensive cancer center. Cost were assessed from intiation of treatment to progression disease and/or to death.The majority of the total costs was formed by targeted drug therapy."@en . "Horov\u00E1, R." . "Anal\u00FDza n\u00E1klad\u016F na 1. linii l\u00E9\u010Dby metastatick\u00E9ho kolorekt\u00E1ln\u00EDho karcinomu p\u0159i pod\u00E1n\u00ED re\u017Eim\u016F s bevacizumabem \u2013 data z re\u00E1ln\u00E9 klinick\u00E9 praxe v \u010Cesk\u00E9 republice" . . . . . "\u0158\u00EDhov\u00E1, Barbora" . "0862-495X" . . "Hradeck\u00E1, Irena" . "RIV/00216224:14110/14:00076429!RIV15-MSM-14110___" . "The Cost Study of First- line Treatment of Metastatic Colorectal Carcinoma with Bevacizumab- containing Regimen in the Czech Republic"@en . "4"^^ . . "3"^^ . . "CZ - \u010Cesk\u00E1 republika" . "Zji\u0161t\u011Bn\u00ED p\u0159\u00EDm\u00FDch n\u00E1klad\u016F na l\u00E9\u010Dbu mCRC u pacient\u016F l\u00E9\u010Den\u00FDch bevacizumabem a chemoterapi\u00ED v prvn\u00ED linii l\u00E9\u010Dby s pou\u017Eit\u00EDm klinick\u00FDch a finan\u010Dn\u00EDch dat z\u00EDskan\u00FDch z komlexn\u00EDho onkologick\u00E9ho centra.N\u00E1klady byly hodnoceny do progrese a /nebo do \u00FAmrt\u00ED pacient\u016F.Nejv\u011Bt\u0161\u00ED pod\u00EDl n\u00E1klad\u016F na l\u00E9\u010Dbu p\u0159edstavovala c\u00EDlen\u00E1 biologick\u00E1 l\u00E9\u010Dba."@cs . "Anal\u00FDza n\u00E1klad\u016F na 1. linii l\u00E9\u010Dby metastatick\u00E9ho kolorekt\u00E1ln\u00EDho karcinomu p\u0159i pod\u00E1n\u00ED re\u017Eim\u016F s bevacizumabem \u2013 data z re\u00E1ln\u00E9 klinick\u00E9 praxe v \u010Cesk\u00E9 republice"@cs . . "drug costs; targeted molecular therapy; bevacizumab; antineoplastic agents; colorectal neoplasms"@en . "6"^^ . "The Cost Study of First- line Treatment of Metastatic Colorectal Carcinoma with Bevacizumab- containing Regimen in the Czech Republic"@en .